Yunnan Baiyao Group Co.,Ltd

Symbol: 000538.SZ

SHZ

53.15

CNY

company-market-status

  • 27.2487

    P/E ratio

  • -0.9568

    PEG ratio

  • 95.50B

    Mrk Cap

  • 0.03%

    Div Yield

Акции в обращение

1796.860032M

Притежавани от вътрешни лица

0.029%

Притежавани от институции

2.861%

  • Highest
    • 71.64
    • 44.86
    • 50.16
    • 47.24
    • 58.21
    • 63.57
    • 62.72
    • 56.53
    • 61.07
    • 54.36
    • 49.85
    • 62.76
    • 58.62
    • 61.70
    • 59.21
    • 64.88
    • 67.70
    • 87.55
    • 69.12
    • 69.79
    • 77.01
    • 95.68
    • 94.62
    • 86.76
    • 90.20
    • 87.27
    • 65.63
    • 64.66
    • 63.21
    • 63.14
    • 64.89
    • 58.18
    • 56.40
    • 60.31
    • 55.00
    • 52.74
    • 55.46
    • 57.57
    • 57.93
    • 57.75
    • 53.73
  • Lowest
    • 69.75
    • 44.86
    • 50.16
    • 47.24
    • 55.53
    • 61.07
    • 61.28
    • 56.53
    • 60.11
    • 53.74
    • 49.85
    • 60.57
    • 58.62
    • 59.89
    • 59.21
    • 63.10
    • 66.21
    • 82.86
    • 69.12
    • 67.86
    • 77.01
    • 91.79
    • 91.70
    • 85.14
    • 88.26
    • 83.68
    • 62.29
    • 63.22
    • 62.65
    • 63.14
    • 64.31
    • 57.14
    • 55.50
    • 59.48
    • 54.23
    • 51.85
    • 53.80
    • 56.61
    • 56.99
    • 56.90
    • 52.92

Информация за компанията

Последващ PE: Healthcare
Индустрия: Drug Manufacturers—Specialty & Generic
ГЛАВЕН ИЗПЪЛНИТЕЛЕН ДИРЕКТОР:Mr. Ming Dong
Служители на пълно работно време:8781
Град:Kunming
Адрес:No. 3686, Yunnan Baiyao Street
IPO:1993-12-15
CIK:

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, Chinese medicine resources, and tea. The company offers its products under the Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong brand names. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Оборотен капитал

202220212020201920182017
Парични средства и инвестиции13056.1118870.8615279.7312994.213017.132666.33
Приемници0.000.000.000.000.000.00
Инвентарна книга7993.218379.2210990.3511746.869994.018663.28
Други836.114166.642681.584560.251054.757024.57
Общо текущи активи35677.0145503.9549260.8844701.3727283.5025103.56
Acc Payable6631.176437.566315.586243.935615.534569.81
Краткосрочен дълг1944.741822.562883.370.001799.080.00
Други текущи пасиви4982.454458.206437.633370.652771.762680.45
Текущи пасиви13558.3612718.3315636.589614.5810186.377524.37

Капиталова структура

Всички числа в милиони

Общо активи

920,65 щ.д.

Общо задължения

395438122,36 щ.д.

Дългосрочен дълг

1,00 щ.д.

Парични средства и екви

254693069,47 щ.д.

Goodwill

0,00 щ.д.

Неразпределена печалба

7927396,78 щ.д.

Обикновени акции

1796,86 щ.д.

Стойност на предприятието

19,58 щ.д.

Дивиденти за маса

ГодиниQ1Q2Q3Q4Общо
19940.0000.0020.0000.0000.002
19950.0000.0000.0000.0040.004
19960.0000.0100.0000.0000.010
19970.0000.0100.0000.0000.010
19980.0000.0080.0000.0000.008
19990.0000.0000.0020.0000.002
20000.0000.0120.0000.0000.012
20010.0000.0090.0000.0000.009
20020.0000.0180.0000.0000.018
20030.0000.0280.0000.0000.028
20040.0000.0520.0000.0000.052
20050.0000.0520.0000.0000.052
20060.0000.0000.0550.0000.055
20070.0000.0000.0370.0000.037
20080.0000.0000.0370.0000.037
20090.0000.1100.0000.0000.110
20100.0000.0000.0730.0000.073
20110.0000.0000.0480.0000.048
20120.0000.0760.0000.0000.076
20130.0000.2140.0000.0000.214
20140.0000.2380.0000.0000.238
20150.0000.0000.3570.0000.357
20160.0000.4290.0000.0000.429
20170.0000.0000.5710.0000.571
20180.0000.0001.0710.0001.071
20190.0001.4290.0000.0001.429
20200.0002.1430.0000.0002.143
20210.0002.7860.0000.0002.786
20220.0001.6000.0000.0001.600
20230.0001.5200.0000.0001.520
Подобни запаси
Може да се интересувате и от
PILL.CN
Canntab Therapeutics Limited.
0.015 CAD
CNQ
CRON
Cronos Group Inc..
1.75 USD
NASDAQ
RMTI
Rockwell Medical, Inc..
3.32 USD
NASDAQ
ATNX
Athenex, Inc..
0.2031 USD
NASDAQ
SCYX
SCYNEXIS, Inc..
2.62 USD
NASDAQ
RDHL
RedHill Biopharma Ltd..
2.2 USD
NASDAQ
CPIX
Cumberland Pharmaceuticals Inc..
1.61 USD
NASDAQ
PRPH
ProPhase Labs, Inc..
9.15 USD
NASDAQ
OGI
OrganiGram Holdings Inc..
0.39 USD
NASDAQ
BOI.PA
Boiron SA.
37.15 EUR
EURONEXT

Frequently Asked Question

Why is your stock tool better than competitors?

Numfin provides most features for free and gives you accurate and expert data about public companies. We also offer unique features like AI copilot that are not found on other platforms

Can I trust the data on your website and where do they come from?

Absolutely. We receive the data from our partners and other official sources, such as popular stock exchanges (NASDAQ, NYSE, and others), SEC.gov, and other official platforms. Our data provider, FinancialModeling, also provides information for portals like Moody's, Harvard, Chevron, and others. All this proves the accuracy and authority of the information.

Who creates the content on your website and is it approved by experts in finance and investing?

All financial data is received from our data provider and then verified by industry experts. Additionally, we use various AI tools like ChatGPT to present content in a user-friendly and well-structured manner.

What problem does your tool solve? Who is the target audience for your tool

Our main goal is to present accurate and expert information about public companies in a structured manner. We work with investors and financial professionals who have a long-term outlook. Our community consists of private investors, business owners, stock analysts, fund managers, and people who are interested in investing.

Why did you decide to create your tool?

While managing our own money, we searched for the best analytical tool to help us better analyze public companies. Most websites that provided analytics for professional investors were expensive, and the cheap tools were either limited in functionality or lacked valuable company data. Even worse, some of them presented incorrect numbers. As a result, we combined our experience in business, IT, and finance to create the most affordable and useful solution for investors and anyone interested in finance and stock analysis.

What is the difference between free and paid options? Should I buy Pro version from start or it's ok to have a free version?

Most features on our website are free so that many people can use it to analyze companies on the world's top stock exchanges. However, some features, such as our artificial intelligence chat, advanced analytics, filters, and storing of vast historical data, require additional servers from our end. Therefore, we rely on your support to keep this amazing project running. If you would like to experience the full potential of our service, we strongly recommend that you purchase the PRO version, which comes with a 30-day money-back guarantee

Who is your team and do they have enough experience?

You can read about our team here, or you can contact us at [email protected] for more information.